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Received 15 September 2006; received in revised form 5 February 2007; accepted 30 March 2007; Available online 5 June 2007AbstractObjective: The ventricular mass is organized in the form of meshwork, with populations of myocytes aggregated in a supporting matrix of
fibrous tissue, with some myocytes aligned obliquely across the wall so as to work in an antagonistic fashion compared to the majority of
myocytes, which are aggregated together in tangential alignment. Prompted by results from animal experiments, which showed a disparate
response of the two populations of aggregated myocytes to negative inotropic medication, we sought to establish whether those myocytes that
aggregated so as to extend obliquely across the thickness of the ventricular walls are more sensitive to beta-blockade than the prevailing
population in which themyocytes are aggregated together with tangential alignment. If the two populations respond in similar differing fashion in
the clinical situation, we hypothesize that this might help to explain why drugs blocking the beta-receptors improve function of the ventricular
pump in the setting of congestive cardiac failure. Methods: We implanted needle probes in 13 patients studied during open heart surgery,
measuring the forces generated in the ventricular wall and seeking to couple the probes either to myocytes aggregated together with tangential
alignment or to those aggregated in oblique fashion across the ventricular walls. In a first series of patients, we injected probatory doses
intravenously, amounting to a total bolus of 40—100 mg Esmolol, while in a second series, we gave fixed yet rising doses of 5, 10, and 20 mg Esmolol
in three separate boluses. Results: Forces recorded in the aggregated myocytes with tangential alignment decreased insignificantly upon
administration of low doses (57.1  12.4 mN! 56.6  7.6 mN), while forces recorded in the myocytes aggregated obliquely across the
ventricular wall showed a significant decrease in the mean (59.3  11.6 mN! 47.4  6.4 mN). Conclusions: The markedly disparate action
of drugs blocking beta-receptors at low dosage seems to be related to the heterogeneous extent, and time course, of systolic loading of the
myocytes. This, in turn, depends on whether the myocytes themselves are aggregated together with tangential or oblique alignments relative to
the thickness of the ventricular walls.
# 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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In previous studies [1—3], we have shown that the
ventricular myocardium is organised in the form of a
three-dimensional mesh of myocytes set in a supporting
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doi:10.1016/j.ejcts.2007.03.048able to function in antagonistic fashion. This is because the
prevailing mass of myocytes, aggregated together with their
long axes tangential relative to the thickness of the
ventricular walls, is responsible for overall constriction of
the ventricular cavity. The opposing arm of the dualistic
system is provided by a population of myocytes, present
throughout the myocardial mesh, which are aggregated such
that their long axes are oblique across the thickness of the
wall, running in the direction from the epicardium to the
endocardium [2,3]. In the normal heart, this population of
obliquely orientated aggregates of myocytes, besides
sustaining ventricular constriction, also has the function of
attenuating the marked systolic mural ventricular thickening
[1—3], thus preserving the shape and size of the ventricularSurgery. Published by Elsevier B.V. All rights reserved.
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population of obliquely orientatedmyocytes is more sensitive
to the negative inotropic action of barbiturates than are the
myocytes that are aggregated with their long axes tangential
to the ventricular walls. In this investigation, we have
continued to explore the action of drugs on the two
populations of myocytes, assessing in this instance the
disparate action of the ultra-short-acting blocker of beta-
receptors, Esmolol [4], known to exert a negative inotropic
effect.
In this respect, it has now been shown that several months
of medication with beta-blockers unexpectedly reduces
morbidity and mortality in patients with mild-to-moderate
chronic cardiac failure [5—9]. Independent of these late
beneficial effects of beta-blockade, we hypothesize that an
initially weak heart benefits instantaneously from treatment
with low doses of drugs that block the beta-receptors, since
we expect the drug to reconcile the pre-existing unbalance of
action of the intrinsic antagonistic structure and function.
This is because the beta-blockade attenuates instantly, and
in more efficient fashion, the forces produced by the
myocytes aggregated with their long axes oblique relative
to the thickness of the ventricular walls, as opposed to the
constrictive forces provided by the myocytes aggregated
with their long axes tangential to the ventricular wall.Fig. 1. The needle force probe (upper panel), 1.5 mm thick and 9 mm long, is
designedwith a lateral window (A) containing the flexural bar (not visible). The
fine bar (B) crossing the base at right angles serves to stabilize the probe
against rotation on the epicardial surface. The lower panel shows how the
probe measures the forces within the slightly spread three-dimensional mesh-
work of myocytes. Some of the myocytes impinge through the lateral window
(A) on the flexural bar (C), which is then deviated from its central position
within the lumen of the needle (D) by forces (fine arrows) engendered by the
myocytes while they contract in axial direction (bold arrows). This deviation is
sensed by a pair of strain gauges (not shown) glued to the flexural bar.
Fig. 2. The left panel shows simultaneous recordings of the electrocardiogram
(ECG), left ventricular pressure (P), and an unloading type of force signal (F1),
which declines during ventricular ejection, as opposed to an auxotonic, or
augmenting, type of signal (F2), which continues to rise throughout ventricular
ejection, outlasting the period of ejection. In the right panel, it can be seen
that the type of signal is the function of the angulation of the aggregated
myocytes to which the flexural bar within the probe is coupled relative to the
epicardial surface. In the upper section, the alignment of the myoctes is
parallel to the epicardium, while in the lower panel, the myocytes are aligned
with an inclined angle relative to the epicardium. Our intention is to achieve an
unloading type of signal with the arrangement shown in the upper panel, and
an auxotonic signal with the angulation illustrated in the lower panel.2. Methods
During an extensive cardiodynamic study on the effect of
partial left ventriculectomy [10], we had the opportunity to
investigate also two small cohorts, comprising patients
undergoing treatment with Esmolol while undergoing various
kinds of cardiac surgical procedures. The patients making up
our first cohort served as a pilot series to establish the
appropriate dosage of Esmolol. All patients were Caucasian,
three male, two female, aged from 57 to 74 years, with a
mean age of 65.8 years, and all were studied during
preparation for coronary arterial surgery. All patients gave
informed consent consistent with the institutional policy of
the Academic Hospital, University of Pretoria, South Africa.
While maintaining standby extracorporeal circulation, we
implanted two force probes [1] into the base of the left
ventricle, one placed close to the atrioventricular junction
and the second in the mid-portion of the ventricle (Fig. 1).
The probes were implanted almost parallel, yet slightly
inclined with respect to the epicardium. Although there is no
way to predict the alignment of the aggregated myocytes by
visualising the epicardial ventricular surface, we sought to
couple, in each patient, one probe to the population of
obliquely intruding myocytes aggregated in oblique direction
from the endocardium to the epicardium [3,4], and which are
known to produce an auxotonic force signal [1]. It was then
our intention to couple the other probe to the prevailing
population of myocytes, which are aggregated with their long
axes tangential relative to the thickness of the wall, and
which produce an unloading type of force signal (Fig. 2). In
two of the five patients, however, we recorded auxotonic
signals from both probes (Table 1). We also measured arterial
pressure in the radial artery as is routinely done during
cardiac surgery. After a control recording, we administered
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Table 1
The alterations in haemodynamic and cardiodynamic conditions induced by pilot doses of Esmolol given to five South African Caucasian patients
Fixed doses of Esmolol, based on the pilot studies, were subsequently administered to eight Amerindian Brazilian patients. mg/dose: mg Esmolol per single dose;
mmHg: millimetres of mercury; mN: milliNewtons; b/min: beats per minute; developed force: systolic minus diastolic values in milliNewtons; the unloading type of
forces are listed on a clear background; the auxotonic type of forces are listed on a shaded background; na: not available.pilot doses of Esmolol, seeking to establish the most
appropriate regime. Thus, the first patient received a bolus
of 100 mg, the second a bolus of 50 mg, the third two boluses
of 50 mg each, followed by two boluses of 25 mg each. We
gave one bolus of 50 mg to the fourth patient, and a bolus of
40 mg to the last patient. Extracorporeal circulation was
started 5 min after the last injection, and routine surgery was
continued after the force probes had been removed.
In our second series, prompted by the most variable dose-
related response of the first group of patients, we
investigated, using markedly lower but rising doses, a further
cohort of eight Amerindian patients, five male and three
female, aged from 45 to 67 years, with a mean age of 57
years. These patients, in six instances, were undergoing
surgery for coronary arterial disease, while the remaining
two patients underwent aortic valvar plasty and mitral and
tricuspid valvar plasty, respectively. These patients all signed
informed consent consistent with the institutional policy of
the Hospital Geral de Roraima, Boa Vista, Brazil. The force
probes were implanted as in the initial cohort. In the first
patient of this second cohort, signals recorded from both
probes were of the unloading type. Otherwise, as was our
intention, the probes recorded either auxotonic or unloading
signals. In six patients, we assessed left ventricular pressure
using a catheter-tipped manometer implanted through the
left ventricular apex. In the other two patients, arterial
pressure was measured via the radial artery, as in the first
cohort of patients. After a control recording, doses of 5, 10,
and 20 mg Esmolol were given intravenously, with an interval
of 3 min between the injections. Thereafter, surgery
proceeded as described above.3. Definitions
Since our study reveals aspects of ventricular mechanics
that may, to some readers, seem divorced from conven-tional wisdom, it may be helpful if we provide precise
definitions of the terms to be used in the subsequent
descriptions.
Tensile force (FT), calibrated in milliNewtons, is the value
measured using the needle probes [1]. After the insertion of
the probe, which is 1.5 mm thick and 9 mm long (Fig. 1),
some of the aggregated myocytes impinge on the flexible bar
in the lateral window of the probe, providing a periodic force
signal (Fig. 2). The signal corresponds to the force that acts
during contraction of the myocytes that are spread around
the lateral window (Fig. 1). As the mesh of myocytes is
slightly spread by the thickness of the probe itself, the signal
has a constant diastolic component, which serves as the
diastolic control. The second, variable, component of the
signal corresponds to the tension generated by the contrac-
tion of the myocytes during systole.
The developed tensile force is evaluated as the systolic
minus the diastolic value.
In classical physiology, the unloading type of signal,
designated FT unload, is the force that exhibits a pronounced
drop during the period of shortening of the aggregated
myocytes along their long axis [1] (Fig. 2), thus heralding a
decrease in afterload. In contrast, the auxotonic, or
augmenting, type of signal, designated FT auxoton, is the
force that increases during the period of ventricular
constriction because the load coupled to the measured
population of myocytes also increases (Fig. 2). We have
shown previously that the unloading signal is recorded when
the probe is coupled to myocytes that are aggregated with
their long axes tangential to the epicardial surface of the
ventricular wall [1]. They are unloaded while ventricular
radius shrinks. Auxotonic, or augmenting, forces are
recorded from myocytes aggregated in an oblique fashion,
thus being exposed to augmentation of the load while mural
thickness increases. When inserting the probes, however,
there is no indicator predicting to which population the
probes are coupled. The type of signal obtained after
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with accuracy. As shown by our previous histological study
[1], nonetheless, the probability of coupling the probe to
obliquely aggregated myocytes, and hence to record an
auxotonic signal, is greater in deeper mural zones than in the
subepicardial regions.
Antagonism is the term we use to describe the dualistic
contractile behaviour of the ventricular myocardium, the
tangential myocardial alignment sustaining a strictly
constrictive action, while the myocytes orientated with
their long axes running obliquely from the epicardium to
the endocardium partially counteract the mural thicken-
ing. Antagonism implies that not all the contractile forces
generated by the ventricular wall act to sustain ventricular
emptying. The presence of the greater amount of myocytes
being aggregated tangentially, while a smaller, yet
significant, number of myocytes aligned with oblique
orientation, all of them acting synchronously, serves to
put the wall itself under stress from all directions, thus
providing self-buttressing and hence stabilising ventricular
shape and size. In the setting of myocardial fibrosis, as
seen in patients with ischaemic heart disease, we
measured the incidence of auxotonic forces to be markedly
greater than in non-ischaemic hearts. We assume, there-
fore, that the supporting matrix of connective tissue, both
in health and disease, plays a pivotal role by deviating
forces in an oblique direction from the epicardium to the
endocardium.4. Statistical analysis
All values are expressed as means plus or minus standard
deviations. We used the Wilcoxon test to determine
statistical significance, along with the Mann—Whitney U-test
for unpaired data. A probability value of p less than 0.05 was
considered significant.Fig. 3. A recording under control conditions from the second patient of our
first cohort, showing the unloading type of contractile force recorded from
some tangentially aggregated myocytes (upper trace), the auxotonic type of
forces recorded from the myocytes aggregated obliquely from epicardium to
endocardium (middle trace), and the pressure in the radial artery (lower
trace), the changes being induced by a single dose of 50 mg Esmolol. Note the
drop in the auxotonic force, shown in the middle trace, subsequent to
administration of Esmolol, and the absence of any drop in the unloading type
of force (upper trace).5. Results
5.1. Pilot cohort of patients
The systolic arterial pressures dropped to various
extents subsequent to beta-blockade at various doses, as
shown in Table 1. Marked decreases in end-diastolic arterial
pressure were seen in three of the five patients, and
unloading forces were also recorded only in three of the five
patients. In these three, the force remaining unchanged in
the second patient subsequent to beta-blockade (Fig. 3),
but dropping by 22% in the first patient and by half in the
fifth patient (Table 1). This latter patient, receiving only
40 mg Esmolol, had the most pronounced drop in heart rate
of all 13 patients, associated also with a marked drop both
in systolic and diastolic arterial pressures. We measured
auxotonic signals at seven sites of impalement. These
signals decreased by 40% in the first and second patients
(Fig. 3), by 30% and 16% in the third patient, by 14% and 23%
in the fourth patient, and by 23% in the fifth patient
(Table 1). Heart rate decreased in all patients, albeit to
markedly varying degrees (Table 1).5.2. Second cohort of patients
Although using appreciably smaller doses of Esmolol, we
noted heterogeneous responses of the systolic and end-
diastolic left ventricular and arterial pressures, respectively,
with the heart rate decreasing to varying extent in all
patients. Overall, the haemodynamic alterations were
statistically insignificant (Table 1). We recorded an unloading
type of force in all eight patients. Subsequent to beta-
blockade, the measured force remained unchanged in four,
fell in two and increased in two (Table 1, Fig. 4). Auxotonic
forces were measured in seven of the eight patients. Mean
values of these forces dropped significantly in all but the
fourth patient (Table 1, Fig. 4). Positive dF/dtmax, as
measured in the patients making up the second cohort of
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than in the unloading type of forces, while for negative dF/
dtmax, the differences were less pronounced (Fig. 4). None of
the changes in velocity of rise, nor that in decline, either forFig. 4. The upper panel shows the changes inmyocardial forces seen in the eight
patients making up our second cohort subsequent to administration of 5, 10, and
20 mg of Esmolol. Note that the drop in auxotonic forces at 20 mg Esmolol is
significant (*) relative to control values, and also relative to some inconsistent
changes in the unloading type of forces. Themiddle panel shows the response of
positive dF/dtmax assessed in the auxotonic and unloading forces. The lower
panel shows the response of negative dF/dtmax in both types of forces. Note that
the changes in velocity of rise anddeclineof both forceswith none of thedosages
used become statistical significant relative to control conditions.the auxotonic or the unloading type of forces, became
statistical significant when related to control conditions.6. Discussion
To our knowledge, the capacity of drugs, such as
barbiturates, to depress contractile forces depending on
the afterload exerted on the myocytes has attracted little, if
any, attention [1]. If we are to understand their therapeutic
actions, we must first appreciate the way the myocytes are
arranged within the ventricular walls. In this respect, we
have shown previously that the amount and the slope of
afterload of an individual myocyte are determined not only
by the global haemodynamic resistance of the ventricular
outflow, but are also the consequence of the geometrical
alignment of the individual myocytes within the ventricular
myocardial mesh [1].
The overall anatomic arrangement of the ventricular walls
is that of a three-dimensional mesh of myocytes set in a
matrix of fibrous tissue, the myocytes themselves being
aggregated such that their long axes either run tangentially
or obliquely relative to the thickness of the ventricular wall
[2—4]. This arrangement permits the contraction of the
aggregated myocytes to create antagonism through the
interaction of unloading and auxotonic forces [1]. The
amount of the auxotonic forces engendered by the myocytes
aggregated with their long axes obliquely through the short
axis of the wall is a function of their inclination, together
with the thickness of the wall. The thicker the wall becomes
at end-systole, the more the myocytes are inclined relative
to the short axis. Hence, the greater is the increment of the
auxotonic forces as the myocytes are deviated in a direction
from the epicardium to the endocardium [2—4], and themore
they counteract the systolic mural thickening [1]. Under
physiological conditions, these two opposing forces provide
balance for the entirety of the ventricular walls, contributing
both to the stability of ventricular shape and the cavity size
[1—3]. As myocardial structure and function are organised in
an antagonistic fashion, we needed to make focal measure-
ments of contractile activity to determine if the active state
of contraction of myocytes aggregated in oblique fashion
persists longer than the period of contraction of themyocytes
aggregated with their long axes tangential to the wall. As
these measurements showed, the contraction of the
obliquely aggregated myocytes does indeed persist beyond
the end of ejection. We presume, therefore, that the
obliquely orientated myocytes are able to act during the
beginning of diastole so as to enhance ventricular dilatation
[1]. When considering this action in the setting of known
clinical data [10], we infer that the primarily beneficial
antagonistic regulation of the dual contractile activity
becomes unbalanced in the setting of congestive heart
failure. In the setting of systemic hypertension, for example,
we infer that, initially, it is only the constrictive performance
of the tangentially aggregated myocytes that is increased.
This results in an increase in mural thickness, which then
additionally increases the loading of those myocytes
aggregated obliquely relative to the thickness of the wall,
and hence also promotes their own hypertrophy. Concomi-
tant with this increase in mural thickness, both arms of the
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providing a stimulus for further hypertrophy in both
populations of myocytes. The key to the therapeutic success
of interrupting the vicious circle inherent in this setting,
therefore, could be to attenuate selectively the dilatory arm
while preserving the constrictive activity of the tangential
population of myocytes.
Beta-blockade, despite its known negative inotropic
effect, has recently been shown to improve global ventri-
cular function when administered over the long term to
patients with cardiac failure of mild and moderate degree
[6—10]. This seemingly paradoxical action has been
explained on the basis of a time-consuming, yet progressive
suspension of the prevailing down-regulation of beta-
receptors [6—9]. Our current results now suggest that an
additional mechanism could be involved. We postulate that
beta-blockade, at low doses, exerts an instantaneous
selective action, which constrains the forces engendered
by those myocytes which are aggregated with their long axes
oblique relative to the short axis of the ventricular wall.
These aggregated myocytes, as we have shown, are more
sensitive to the depressant action of beta-blockade than the
prevailing tangentially aggregated myocytes, the latter cells
engendering the constrictive activity [1—3].
In the majority of our patients, however, our chosen doses
were such as to provide unintentional dual relief in
contractility, mediating also a drop in systemic systolic
pressure. This shows that, for most of the patients, these
chosen doses were too high, since they also attenuated the
action of those prevailing tangential aggregates of myocytes
that sustain ventricular ejection and/or reduce also systemic
vascular resistance. On the other hand, we anticipate that, in
an antagonistic system, the attenuation of the one arm
indirectly also unloads the other opposing arm. This effect
would explain our observed findings in some patients of a
concomitant drop in unloading forces without any decline in
arterial pressure. The significance of such potential mutual
interaction of the two arms of intramural myocardial
antagonism must as yet remain speculation because, for
methodological constraints, we are unable to measure both
activities confocally at their common site of action. Ourfindings nonetheless confirm the obliquely orientated
myocytes, which contract auxotonically, to be the primary
target of Esmolol when this drug is given in low doses. The
findings also point to the need for a more extended study
exploring appropriate doses. A clinical trial would also be
justified to show that beta-blockade, given at low dosage
over the long term, is able to sustain the selective
attenuation of the auxotonic arm of the intramural
myocardial antagonism.
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